INVS and neoplasm: Finding that the expression of INVS and its interactome partners was not responsive to therapy with immune checkpoint inhibitors in ccRCC (as well as other types of immune-dependent carcinoma) supports their upstream position in the regulation of the inflammatory tumor microenvironment.